Revolutionizing the Fight Against Transplant Rejection: Producing Tregs to Scale to Prevent Graftvs- Host Disease Following Hematopoietic Stem Cell Transplantation

Time: 2:30 pm
day: Day Two | Track A | Afternoon


  • Enrichening donor grafts with a defined ratio of Tregs to T cells prevents GVHD in clinical populations
  • Utilizing centralized manufacturing methods of HSCT grafts to scale up for large scale studies
  • Improving Tregs with direct modification or combination therapy to further enhance hematopoietic stem cell transplantation and transplantation tolerance